Core Insights - The iShares U.S. Pharmaceuticals ETF (IHE) is currently trading at a forward earnings multiple of 15.69x and is projected to see an earnings per share growth of 19.07% over the next twelve months according to analysts [1] Group 1: ETF Overview - The iShares U.S. Pharmaceuticals ETF (IHE) focuses on the pharmaceutical sector within the U.S. equity market [1] - The ETF is analyzed using a proprietary ranking system that evaluates nearly 1,000 ETFs based on various factors including costs, liquidity, risk, size, value, dividends, growth, quality, momentum, and sentiment [1] Group 2: Analyst Background - The Sunday Investor, who covers U.S. Equity ETFs, has a strong analytical background and holds a Certificate of Advanced Investment Advice from the Canadian Securities Institute [1] - The Sunday Investor has completed all educational requirements for the Chartered Investment Manager designation [1]

Global Payments Inc. (NYSE:GPN) is included among the 14 Best GARP Stocks to Buy According to Analysts. Cantor Fitzgerald Raises Global Payments (GPN) Price Target, Says Q4 Cleared Key Overhang On February 23, Cantor Fitzgerald analyst Ramsey El-Assal raised the price recommendation on Global Payments Inc. (NYSE:GPN) to $88 from $80. The analyst reiterated a Neutral rating on the stock. He told investors that the company’s Q4 results acted as a clearing event. He noted that FY26 guidance points to 5% adj ...

In this article, we will take a look at the 14 Best GARP Stocks to Buy According to Analysts.Innovation and rapid technological change, driven by the rise of artificial intelligence, are reshaping markets. AI is increasingly seen as a source of profits and productivity gains, and that has shifted how investors think about growth and valuation. Markets have experienced similar booms before. Many of them ended with volatility. This time, though, the belief that AI represents a lasting shift has allowed sentim ...

Key Takeaways There are some similarities but also key differences between the Nifty 50 & Mag 7.Mag 7 stocks currently trade at a slim premium to the S&P 500 Index.Leaders like MSFT have transformed into GARP plays. What were the Nifty 50?The “Nifty 50” was a group of 50 of the most followed, large-cap stocks on the NYSE that flourished in the 1920s and early 1970s. The group of stocks included well-known, popular companies such as Walmart (WMT), Polaroid, Xerox (XRX), and Coca-Cola (KO). During the early 1 ...

I last reviewed the Invesco S&P SmallCap Momentum ETF ( XSMO ) on July 15, 2025, when I rated it a "buy" on account of its outstanding GARP features and relatively high quality. Since that article was published, XSMO has gained 17.41%, outpacingThe Sunday Investor is focused exclusively on U.S. Equity ETFs. He has a strong analytical background, has received a Certificate of Advanced Investment Advice from the Canadian Securities Institute, and has completed all the educational requirements for the Chartere ...

I last reviewed the Invesco S&P SmallCap Momentum ETF ( XSMO ) on July 15, 2025, when I rated it a "buy" on account of its outstanding GARP features and relatively high quality. Since that article was published, XSMO has gained 17.41%, outpacingThe Sunday Investor is focused exclusively on U.S. Equity ETFs. He has a strong analytical background, has received a Certificate of Advanced Investment Advice from the Canadian Securities Institute, and has completed all the educational requirements for the Chartere ...

Core Insights - Celestica (CLS) is positioned as a strong player in AI infrastructure, likened to a classic "picks and shovels" investment strategy, which typically benefits from the growth of the AI sector [1] - The investment philosophy of Kennedy Njagi, a hedge fund manager, focuses on companies with aggressive growth prospects and aims for high profitability within 1-2 years [1] - The emphasis is on long-term discipline and consistent alpha generation, while also acknowledging the inherent risks involved in such investments [1] Company Analysis - Celestica is seen as a beneficiary of the growing demand for AI infrastructure, indicating potential for significant revenue growth [1] - The company is likely to attract investors looking for growth-oriented opportunities in the technology sector, particularly in AI [1] Investment Philosophy - The investment approach highlighted includes a focus on GARP (Growth at a Reasonable Price) strategies, which may appeal to investors seeking a balance between growth and valuation [1] - The philosophy also includes a commitment to improving financial literacy and empowering underprivileged communities, suggesting a socially responsible investment angle [1]

Core Viewpoint - Invesco S&P 500 GARP ETF (SPGP) provides exposure to growing companies with reasonable valuations, targeting businesses within the S&P 500 that exhibit revenue and earnings growth without excessive price multiples [2]. Portfolio Strategy: Growth Without Overpaying - SPGP employs a quantitative screening process to identify companies with strong growth characteristics and attractive valuation ratios, managing $2.4 billion primarily in cyclical sectors that benefit during economic expansions [3]. - The fund allocates 24.8% of its assets to financials, capitalizing on rising interest rates and increased lending activity, followed by significant investments in Consumer Discretionary and Industrials as consumer confidence and business investment rise [3]. Performance That Rewards Patience - Over the past year, SPGP returned 9.5%, underperforming the S&P 500's 14.4% due to weakening consumer sentiment affecting discretionary spending and travel demand [5]. - In a five-year view, SPGP gained 60%, lagging behind SPDR S&P 500 ETF Trust's 77% return, highlighting the need for economic tailwinds for the strategy to outperform [5]. The Tradeoffs You Accept - The fund is most effective during economic expansions and consumer spending increases, avoiding defensive sectors and lacking a buffer during growth slowdowns [6]. - SPGP offers a minimal dividend yield of 0.65%, and concentration risk is present, with the top 25 holdings comprising approximately 40% of total assets [6].

Let me cut to the chase. Micron Technology (NASDAQ: MU ) is still a great Strong Buy. The company's earnings report confirms that since my last coverage of the stock. And the company isKennedy is a GARP-themed investor with a bias towards companies with aggressive growth prospects, en route to becoming highly profitable in 1-2 years.His investment philosophy emphasizes long-term discipline, consistent alpha, and a pinch of salt (risk).He writes to empower the underprivileged and improve financial literacy.T ...

Core Viewpoint - Micron Technology (NASDAQ: MU) is identified as a strong buy, supported by the company's recent earnings report which confirms its growth potential [1]. Company Summary - The company is positioned for aggressive growth and is expected to become highly profitable within 1-2 years [1]. - The investment philosophy surrounding Micron emphasizes long-term discipline and consistent alpha generation, indicating a focus on sustainable growth [1].